Cyclacel Pharmaceuticals Inc.

(CYCC) Trade

By |

Profile

Cyclacel Pharmaceuticals Inc mainly develops targeted medicines for cancer and other proliferative diseases. The company focuses in hematology and oncology-based development pipeline of novel drug candidates.

Contact Information

Website: www.cyclacel.com
Email: ir@cyclacel.com
Main Phone: +1 908 517-7330
Address: 200 Connell Drive
Address 2: Suite 1500
State: NJ
City / Town: Berkeley Heights
Country: USA
Postal Code: 07922

Issuer Information

Exchange: NSC
CEO: Spiro Rombotis
Employees: 12
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 1.51 $ 0.0494 (3.38%)
Last Price 1.51 Change $ 0.0494 Change % 3.38 Tick N/A
Bid 1.30 Bid Size 200.00 Ask 1.80 Ask Size 4,000.00
Open 1.52 High 1.53 Low 1.49 Prev Close 1.46
Last Trade Volume 31,197 52 Wk Hi 3.41 52 Wk Low 1.28
Market Cap 18.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 11,997,447.00 EPS (TTM) -1.42 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
Samuel L. Barker 1,000
Paul McBarron 1,000
Paul McBarron 1,000
Lloyd M. Sems 1,000
Spiro Rombotis 1,000
Spiro Rombotis 1,000
Paul McBarron 1,000
Spiro Rombotis 1,000
Spiro Rombotis 1,000
Spiro Rombotis 1,000
Last 10 Sell Shares
Robert Sosnowski 1,000
Spiro Rombotis 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 7 7 7 7
Low Target Price Estimate 7 7 7 7
Mean Target Price Estimate 7 7 7 7
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 05/15/18 05/15/18 05/15/18 05/15/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 0
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 0